Svenska
Glossary
Search
Media Releases 2012
Media Archive
Presentations
Image Bank
Calendar
Media Contact
Media Releases 2012
February 4, 2013
Newron together with NeuroNova receives €2.5m Strategic Translation Award from Wellcome Trust to develop experimental drug candidate for ALS
December 17, 2012
Newron closes acquisition of NeuroNova
© NeuroNova AB, Sweden, Tel: +46 (0)8 786 0900, Email: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Sitemap
Site policy
Project Pipeline
Project
Indication
Pre-clin.
IND
Phase I/II
Phase II
Phase III
sNN0029
ALS
sNN0031
Parkinson's disease
More about our Projects
Business Development
NeuroNova’s business strategy centers on developing novel therapeutic products based on neurogenesis in areas of high unmet medical need in neurodegenerative diseases.
More about business development.
